These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36756345)

  • 1. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy.
    Hu WZ; Cao LX; Yin JH; Zhao XS; Piao YS; Gu WH; Ma JH; Wan ZR; Huang Y
    Front Neurol; 2022; 13():1081219. PubMed ID: 36756345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non motor symptoms in progressive supranuclear palsy: prevalence and severity.
    Radicati FG; Martinez Martin P; Fossati C; Chaudhuri KR; Torti M; Rodriguez Blazquez C; Vacca L; Stocchi F
    NPJ Parkinsons Dis; 2017; 3():35. PubMed ID: 29238748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.
    Murthy M; Fodder K; Miki Y; Rambarack N; De Pablo Fernandez E; Pihlstrøm L; Mill J; Warner TT; Lashley T; Bettencourt C
    Acta Neuropathol; 2024 Jul; 148(1):4. PubMed ID: 38995454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Non-Motor Symptom Profile of Progressive Supranuclear Palsy.
    Chaithra SP; Prasad S; Holla VV; Stezin A; Kamble N; Yadav R; Pal PK
    J Mov Disord; 2020 May; 13(2):118-126. PubMed ID: 32241079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative Analysis.
    Liu H; Huang Z; Deng B; Chang Z; Yang X; Guo X; Yuan F; Yang Q; Wang L; Zou H; Li M; Zhu Z; Jin K; Wang Q
    Aging Dis; 2023 Feb; 14(1):204-218. PubMed ID: 36818554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
    Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.
    Habibi M; Oertel WH; White BJ; Brien DC; Coe BC; Riek HC; Perkins J; Yep R; Itti L; Timmermann L; Best C; Sittig E; Janzen A; Munoz DP
    J Neurol; 2022 Sep; 269(9):4920-4938. PubMed ID: 35501501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
    Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
    PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy.
    Ou R; Song W; Wei Q; Chen K; Cao B; Hou Y; Zhao B; Shang H
    Parkinsons Dis; 2016; 2016():9730319. PubMed ID: 27366342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
    BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid levels in Parkinson's disease and related disorders.
    Sakuta H; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Watanabe Y; Hirata K
    Brain Behav; 2017 Jan; 7(1):e00598. PubMed ID: 28127516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.